1. Home
  2. Live Updates
  3. Moleculin doses first patient

Live Breaking News & Updates on Moleculin Doses First Patient

Stay updated with breaking news from Moleculin doses first patient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Virtual Investor: Moleculin Doses First Patient in Phase 2 Study for AML - Form 8-K -October 17, 2023 at 09:03 am EDT

Virtual Investor: Moleculin Doses First Patient in Phase 2 Study for AML


Participants:







●

. ....

Jenene Thomas , Wally Klemp , Moleculin Bio , Walter Klemp , Exchange Commission , Virtual Investor , Moleculin Doses First Patient , Chief Executive Officer , Moleculin Biotech , Chief Executive , Soft Tissue Sarcomas , Virtual Investor What ,